SATB2 and cancer: This finding may be of clinical interest because when a cancer of unknown primary is detected in a celiac patient, a SBA should not be excluded a priori even if it proves to be SATB2-positive, considering that celiac disease patients have a significantly higher risk for SBA development in comparison to the general population [31].